OOIR: Observatory of International Research

Papers

(The H4-Index of Progress in Retinal and Eye Research is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The neuroimmune interface in retinal regeneration	246
In vivo application of base and prime editing to treat inherited retinal diseases	239
Widefield OCT angiography	238
Cell identity changes in ocular surface Epithelia	150
Immunological aspects of RPE cell transplantation	141
Non-vasogenic cystoid maculopathies	128
Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics	124
Animal models for the evaluation of retinal stem cell therapies	102
Editorial Board	101
Unravelling CYP4V2: Clinical features, genetic insights, pathogenic mechanisms and therapeutic strategies in Bietti crystalline corneoretinal dystrophy	100
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	99
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	97
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	94
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	94
Central serous chorioretinopathy: An evidence-based treatment guideline	92
Corneal stromal repair and regeneration	89
Editorial Board	88
Squishy matters – Corneal mechanobiology in health and disease	82
Myocilin misfolding and glaucoma: A 20-year update	80
Risk factors, clinical features and treatment of Behçet's disease uveitis	80
A paradigm shift in retinal detachment repair: The concept of integrity	76
Photocoagulation for retinal vein occlusion	74
Homeostatic plasticity in the retina	73
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	72
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	72

Cell fate decisions, transcription factors and signaling during early retinal development	69
Editorial Board	68
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	68
Protection against corneal hyperosmolarity with soft-contact-lens wear	66
RNA-targeting strategies as a platform for ocular gene therapy	64
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	63
Approaches for corneal endothelium regenerative medicine	62
How gut microbiota may impact ocular surface homeostasis and related disorders	62
Genetic architecture of congenital cataracts: correlation of pathogenic variants with morphology and clinical outcomes	62
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	61
The retinal pigmentation pathway in human albinism: Not so black and white	61
Cellular component transfer between photoreceptor cells of the retina	60
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	60
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	59
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	58
Editorial Board	57
Optical coherence tomography angiography in diabetic retinopathy	57
Rhodopsin, light-sensor of vision	57
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	55
Retinal pigment epithelium 65 kDa protein (RPE65): An update	55
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	55
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	54
Regulation of lens water content: Effects on the physiological optics of the lens	54
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	53
The march to harmonized imaging standards for retinal imaging	52
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)	50